Navigation Links
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
Date:11/2/2009

al hazard to a fetus. A Ribavirin Pregnancy Registry has been established to monitor maternal-fetal outcomes of pregnancies in female patients and female partners of male patients exposed to ribavirin during treatment, and for six months following cessation of treatment. Physicians and patients are encouraged to report such cases by calling 1-800-593-2214.

Incidence of Adverse Events

Most common adverse reactions ( > 40%) in adult patients receiving either PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, headache, rigors, fevers, nausea, myalgia, and anxiety/emotional lability/irritability. Most common adverse reactions ( > 25%) in pediatric patients receiving PEGINTRON/REBETOL are pyrexia, headache, neutropenia, fatigue, anorexia, injection site erythema, and vomiting.

In a study with PEGINTRON/REBETOL (weight-based) combination therapy in adult patients, anemia with weight-based dosing was 29%; however, the majority of these cases were mild and responded to dose reductions. The incidence of serious adverse reactions reported for the weight-based REBETOL group was 12%. In many but not all cases, adverse reactions resolved after dose reduction or discontinuation of therapy. Some patients experienced ongoing or new serious adverse reactions during the 6-month follow-up period. Discontinuations for adverse events were 15% and were related to known interferon effects of psychiatric, systemic (e.g., fatigue, headache), or gastrointestinal adverse reactions. Dose modifications due to adverse reactions occurred in 29% of patients.

Most common adverse reactions with PEGINTRON/REBETOL (weight-based) combination therapy were psychiatric, which occurred among 68-69% of patients. These psychiatric adverse reactions included most commonly depression, irritability, and insomnia, each reported by approximately 30-40% of subjects in all treatment groups. Suicidal behavior (ideati
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015 Point-of-Care Partners, a ... consulting firm, has launched the ePA State Navigator ... IT vendors, payers and pharmacies to quickly assess ... authorization (ePA) of prescription medications. Today, ... are completed through time-consuming, manual processes amongst prescribers, ...
(Date:3/31/2015)... ROCHELLE, N.Y. , March 31, 2015 /PRNewswire-USNewswire/ ... it will be featured in the American Medical ... by ITN Productions. AMGA,s "High Performing ... on the challenges facing the nation,s healthcare system ... Medical Letter is profiled along with other leading ...
(Date:3/31/2015)... March 31, 2015 RnRMarketResearch.com ... market research report of 68 pages with latest ... intelligence library. The report "Pemphigus - Pipeline Review, ... therapeutic development for Pemphigus , complete with ... drug target, mechanism of action (MoA), route of ...
Breaking Medicine Technology:Point-of-Care Partners Launches the ePA State Navigator 2AMGA's High Performing Health News Program Features The Medical Letter 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4
... , , ... Inc.,("Chindex") (Nasdaq: CHDX ), a leading independent American provider of ... that the Company will attend the 21st Annual Piper Jaffray,"Unplugged" Health ... the,New York Palace Hotel. , Management is ...
... SAN DIEGO, Nov. 24 Anadys Pharmaceuticals, Inc. (Nasdaq: ... 21st Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, ... conference is being held at The New York Palace Hotel. ... Anadys, will provide an overview of Anadys and its clinical ...
Cached Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2
(Date:4/1/2015)... The term “420” is thought to have originated ... of California teenagers would regularly get together after school to ... become a short-hand term for cannabis use – and April ... holiday for the marijuana culture. , To help celebrate this ... that help bring cannabis businesses and consumers together, has a ...
(Date:4/1/2015)... On April 1st, 2015, Dr. Jason Helfrich, co-founder of ... to discuss the epidemic known as “Text Neck.” The average human ... in which it is bent forward, such as when bent to ... can cause poor posture often times leading to wear and tear ... hours on their cell phone device emailing, keeping up with social ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Poisonous plants ... from climate change in recent years, increasing significantly in ... allergic reaction if exposed to poison plants (according to ... and families prepare for summer adventures in nature, they ... poison plant reaction is greater than ever. This year, ...
(Date:3/31/2015)... On November 24, 2014, Per Wickstrom had an opportunity ... problem of substance abuse and the solutions that are offered ... and recovery, gives a unique first-person perspective on addiction and ... the New York Giants, Taylor’s early career was almost cut ... he was able to straighten out long enough to make ...
(Date:3/31/2015)... In conjunction with the Asbestos Awareness ... Mesothelioma Applied Research Foundation (Meso Foundation) announced the ... its existing work in mesothelioma research, education, support, ... Meso Foundation’s mission, we want to eliminate harmful ... asbestos, including mesothelioma,” said the Meso Foundation’s executive ...
Breaking Medicine News(10 mins):Health News:The WeedLife Network Marks the Marijuana Culture’s 420 Celebrations by Offering Steep Advertising Discounts 2Health News:The WeedLife Network Marks the Marijuana Culture’s 420 Celebrations by Offering Steep Advertising Discounts 3Health News:Dr. Jason Helfrich, Co-Founder of 100% Chiropractic, is a Guest on Better TV to Discuss “Text Neck” 2Health News:New Ivarest Poison Ivy Itch Spray Provides All-Day Comfort 2Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Mesothelioma Research Organization Announces New Prevention Program 2Health News:Mesothelioma Research Organization Announces New Prevention Program 3
... ... ... approaches many men are looking forward to gifts of hand-made cards, refrigerator art, and pencil holders ... for those men who are trying to become dads, the day may come packed with many ...
... sugar disease help cause malignancy, or just share common ... People with diabetes may have something else to be ... to a new consensus report produced by experts recruited ... Diabetes Association. , Diabetes, primarily type 2 diabetes, ...
... Improve your ... vacation. These resources make it easy! , ... (PRWEB) June 16, 2010 -- Cycling is widely credited with health benefits, environmental protection and ... at home or away and rekindle the joy on two wheels by renting a bike. , ...
... , ... Health Talk Radio on HealthRadio.net, the show with real experts and real answers., , ... Fargo, ND (Vocus) June 16, 2010-- ... Derrick DeSilva, M.D., gives listeners the opportunity to ask leading natural health experts, doctors and ...
... ... ... -- Enovate , a leading provider of mobile and wall-mounted computer workstations, announced ... South American healthcare markets. Similar to the United States, the healthcare industry abroad is ...
... Cabo ... Center For Mind Science, presents the conference: Concepts and Super-Thinking Practices of Patanjali . During ... be guided on an intensive journey into the inner workings of the mind and how ... ...
Cached Medicine News:Health News:7.3 Million US Men and Their Partners Face Fertility Issues 2Health News:7.3 Million US Men and Their Partners Face Fertility Issues 3Health News:Scientists Tease Out Links Between Diabetes, Cancer 2Health News:Scientists Tease Out Links Between Diabetes, Cancer 3Health News:Summer Bike Rentals Improve Your Life at Home and on Vacation 2Health News:Dr. DeSilva Hosts Swanson Health Talk Radio on HealthRadio.net 2Health News:Dr. DeSilva Hosts Swanson Health Talk Radio on HealthRadio.net 3Health News:Enovate Announces Global Expansion 2Health News:Dual Purpose Vacations Combine Yoga Spa Vacation in Cabo San Lucas, Mexico, With Authentic Yogic Miracles Conference 2
... The latest in Canons DR innovations, ... DR system. With a compact and lightweight ... positioned, just like conventional screen-film cassettes. It ... that are difficult to get with fixed ...
The Oscor PACE 101 H is an external single chamber cardiac demand pacemaker. The PACE 101 H feature an option for a atrial overdrive stimulation....
... Oscors proprietary quadripolar pacing ... consistent pacing and sensing in ... combining two bipolar wires in ... for the atrium and ventricle ...
... TME 227 T is a ... temporary cardiac pacing and monitoring ... The TME 227 T features ... myocardium, which allows safe and ...
Medicine Products: